Adicet stock jumps 10% on FDA fast track status for ADI-270 (NASDAQ:ACET)
2024-07-08
Iryna Drozd Adicet Bio (NASDAQ:ACET) stock jumped 10% Monday morning after the company said it had received FDA fast track designation for its CAR-T cell therapy candidate ADI-270 for the treatment of metastatic/advanced clear cell renal cell carcinoma, a type of kidney cancer. The designation was granted for the treatmentContinue Reading